Article
U.S. FDA declines to approve Eton Pharma's anti-seizure drug
Rating:
0.0
Views:
47
Likes:
1
Library:
1
Eton Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration declined to approve its anti-seizure drug lamotrigine, sending the drugmaker's shares down 13% in extended trading.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value